LDA pathology features lead thyroid cancer recurrence model
A retrospective study of 310 patients found that LDA features from pathology reports produced the best-performing XGBoost model for differentiated...
Research report: Adjuvant EGFR-TKI therapy in completely resected non–small cell lung cancer with major uncommon EGFR mutations: a real-world study
A retrospective study of 154 patients links adjuvant EGFR inhibitors with longer three-year disease-free survival after surgery for non-small cell...
Systematic review maps tyrosine kinase inhibitor evidence in canine solid tumours
A systematic review of 200 publications found the clearest clinical evidence for tyrosine kinase inhibitors in canine mast cell tumours,...
TCR-engineered T cells advance toward harder liver cancer targets
A 2026 review finds that TCR-engineered T cells have entered early clinical testing for hepatocellular carcinoma, but safety, antigen heterogeneity...
An integrated spatially defined roadmap of normal and cancer-associated colon fibroblasts
A single-cell, spatial and functional study maps normal human colon fibroblasts and identifies four cancer-associated subsets in colorectal cancer.
Commentary proposes etiological tumor classification for clinical research
A 2026 commentary proposes classifying tumors as innate, acquired or combined-etiology while describing the framework and its therapeutic implications as...
Research report: Swallowing exercise adherence in patients with head and neck cancer based on the dual-process model: a qualitative study
A qualitative study of 18 patients with head and neck cancer found that swallowing-exercise adherence involved interactions between habitual cues,...
Protocol plans randomized comparison of kidney-protective drugs during HIPEC
A planned 90-patient randomized trial will compare cilastatin with sodium thiosulfate for preventing acute kidney injury during cisplatin-based HIPEC, but...
ACSS2 inhibition boosts cabozantinib activity in liver cancer models
Preclinical hepatocellular carcinoma models showed that blocking ACSS2 or autophagy enhanced cabozantinib’s antitumor activity by disrupting a TFEB-linked protective response.
Research report: Targeting the gut-liver axis: New review explores microbial modulation to enhance immunotherapy in hepatocellular carcinoma
A systematic review finds that gut microbes and metabolites may shape the liver immune environment associated with immunotherapy response in...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!